Hunan Dajiaweikang Pharmaceutical IndustryLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Shengli Hu
Chief executive officer
CN¥637.9k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4.2yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 6.1yrs |
Recent management updates
Recent updates
There's Reason For Concern Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Massive 41% Price Jump
Oct 08Optimistic Investors Push Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Shares Up 30% But Growth Is Lacking
May 09Market Might Still Lack Some Conviction On Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Even After 31% Share Price Boost
Mar 08CEO
Shengli Hu (50 yo)
4.2yrs
Tenure
CN¥637,900
Compensation
Ms. Shengli Hu is GM, Financial Director & Director of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd from July 28, 2022. She was Financial Director, Board Secretary & Director of Hunan Dajiaweikang Ph...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
GM, Financial Director & Director | 7.2yrs | CN¥637.90k | no data | |
Director & Deputy GM | 1.1yrs | CN¥386.60k | 0.097% CN¥ 2.2m | |
Chairman of the Board | 4.4yrs | CN¥685.80k | 34.15% CN¥ 786.3m | |
Director | 10.4yrs | CN¥240.00k | 9.39% CN¥ 216.2m | |
Chairman of the Supervisory Board | 7.2yrs | no data | 0.094% CN¥ 2.2m | |
Independent Director | 5yrs | CN¥160.00k | no data | |
Independent Director | 4.2yrs | CN¥160.00k | no data | |
Supervisor | 7.2yrs | no data | no data | |
Employee Representative Supervisor | 10.4yrs | no data | no data | |
Independent Director | 1.1yrs | CN¥42.60k | no data |
6.1yrs
Average Tenure
51.5yo
Average Age
Experienced Board: 301126's board of directors are considered experienced (6.1 years average tenure).